"Assessing Barriers to ADA Guideline Adherence"
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00503464|
Recruitment Status : Unknown
Verified July 2012 by Agency for Healthcare Research and Quality (AHRQ).
Recruitment status was: Recruiting
First Posted : July 18, 2007
Last Update Posted : July 19, 2012
|Condition or disease|
Study hypothesis: Questionnaire responses about perceived barriers to implementation of diabetes care recommendations, administered to primary care providers and staff, will be shown to correlate with that provider's and practice's success at implementing care guidelines.
Diabetes care in the U.S. consistently fails to meet recommended quality standards. Barriers impede the translation of evidence-based guidelines into sustainable practice. Few studies have considered multiple barriers, and there is a lack of evidence-based strategy in choosing interventions to overcome barriers. This study involves a comprehensive assessment of practice barriers to diabetes guidelines adherence across a primary care network. The BAT based upon a framework proposed by Cabana, et al (1999) will be validated to correlate with provider and practice adherence to diabetes care guidelines. A Diabetes Flow Sheet implemented in our Network to track adherence to guidelines will be assessed and correlated with measured barriers. This organizational strategy will support an evidence-based approach to quality initiative interventions. The BAT will be administered to practice team members: providers, support staff, and practice managers in our Network of 25 primary care practices. Five hypotheses are tested:
A: The BAT measures perceived barriers to adherence to diabetes guidelines, while showing adequate internal consistency and an identifiable subscale structure.
B: The BAT results inversely correlate with practice and provider adherence to ADA guidelines.
C: BAT scores will inversely correlate with use of the Diabetes Flow Sheet.
D: The BAT scores inversely correlate with clinical outcomes (glycemic and lipid control.)
E: Use of the Diabetes Flow Sheet correlates with higher provider and practice adherence to ADA guidelines.
The BAT would then provide the structure for comprehensive assessment of barriers. Study of the Crozer-Keystone PBRN is a real-world laboratory for research in the translation of evidence into diverse practices. The Network is optimally positioned to implement and study this organizational strategy.
|Study Type :||Observational|
|Official Title:||"Assessing Barriers to American Diabetes Association Guideline Adherence"|
|Study Start Date :||September 2006|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00503464
|Contact: Anne M Allie, B.S.||firstname.lastname@example.org|
|United States, Pennsylvania|
|Crozer-Keystone Health System Practice-Based Research Network||Recruiting|
|Upland, Pennsylvania, United States, 19013|
|Contact: Anne M. Allie, B.S. 610-579-3491 email@example.com|
|Principal Investigator: Mitchell A. Kaminski, M.D., M.B.A.|
|Principal Investigator:||Mitchell A. Kaminski, M.D., M.B.A.||Crozer-Keystone Health Network|